These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1882605)

  • 1. [The specific activity of a multicomponent vaccine made from the antigens of opportunistic microorganisms].
    Mansurova NL; Egorova NB; Kaverina KG; Poliachenko VM; Lobova EA
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Apr; (4):39-41. PubMed ID: 1882605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The antigen-specific activity of a multicomponent vaccine administered orally and subcutaneously].
    Mansurova NL; Chuprinina RP; Egorova NB; Kuz'mina LA; Skorikova IG; Kaverina KG
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):37-9. PubMed ID: 7539974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The results of experimental and clinical studies of a multicomponent vaccine made of the antigens from opportunistic microorganisms].
    Egorova NB; Efremova VN; Kurbatova EA; Kuz'mina LA
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (6):96-101. PubMed ID: 9460881
    [No Abstract]   [Full Text] [Related]  

  • 4. [The antigenic activity of vaccines made from opportunistic microorganisms in an experiment to immunize animals by oral and combined methods].
    Efremova VN; Poliachenko VM; Kaverina KG
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Feb; (2):40-3. PubMed ID: 1441812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An evaluation of the protective activity of a multicomponent vaccine made from opportunistic microorganisms in the oral method of immunization in a model of local staphylococcal infection].
    Efremov VN; Poliachenko VM
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (4):73-6. PubMed ID: 8067121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The protective activity of a multicomponent vaccine made from the antigens of opportunistic microorganisms when administered orally].
    Egorova NB; Mansurova NL; Kuz'mina LA; Kaverina KG
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):48-51. PubMed ID: 8067073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Elimination of Klebsiella pneumoniae and humoral immunity in immunization with the IS-4 immunostimulating mixture].
    Mansurova NL
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):71-5. PubMed ID: 3518307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The mutagenicity of a new multicomponent vaccine made from the antigens of Klebsiella pneumoniae, Staphylococcus aureus, Proteus vulgaris and Escherichia coli].
    Volgareva GM; Tolcheev IuD; Egorova NB; Mansurova NL; Silin AM; Anpilogova OR
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jun; (6):50-2. PubMed ID: 1887711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protective activity of a cell-free Klebsiella vaccine in infection in mice caused by Streptococcus pneumoniae serotypes].
    Kurbatova EA; Egorova NB; Krasnoproshina LI; Rodionychev EA; Mansurova NL
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Feb; (2):60-5. PubMed ID: 3887815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ChemicaL and immunochemical characteristics of antigenic preparations from Staphylococcus aureus and Klebsiella pneumoniae as the components for an associated vaccine].
    Shagam NL; Efremova VN; Kurbatova EA; Kaverina KG
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Jun; (6):51-5. PubMed ID: 3140544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Naso-subcutaneous application of the polycomponent vaccine VP-4 for the treatment of patients with bronchial asthma and chronic obstructive bronchitis].
    Antonova LP; Markova TP; Kurbatova EA
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (6):36-40. PubMed ID: 15636137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proteus peritonitis-bacteremia in mice--a model for studying postvaccinal Proteus immunity].
    Zaĭtsev EV; Levina LA
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Jul; (7):74-8. PubMed ID: 2251896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of therapeutic polycomponent vaccine "Immunovac VP-4" for the treatment of chronic bacterial prostatitis].
    Bondarenko VM; Vershinin AE; Kucherskiĭ VM; Mitkov VG; Klimova NE; Kurbatova EA; Egorova NB
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (3):39-43. PubMed ID: 15346948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental study of the immunogenicity of a monopreparation of Klebsiella pneumoniae antigen complex and its association with Staphylococcus, Proteus and Escherichia coli antigens].
    Egorova NB; Mansurova NL; Kurbatova EA; Efremova VN; Kreĭnin LS
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):35-8. PubMed ID: 6367319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunostimulating activity of combined antigens of Klebsiella pneumoniae, Staphylococcus, Proteus and Escherichia coli and separate components in cross infection].
    Egorova NB; Kreĭnin LS; Efremova VN; Kaverina KG; Mansurova NL
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Sep; (9):70-4. PubMed ID: 3907218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study of the immunological activity of a preparation made from the antigenic complexes of opportunistic microorganisms administered by different routes].
    Kuz'mina LA; Vlasov GS; Egorova NB; Salov VF; Sergeeva GS
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jan; (1):59-63. PubMed ID: 3551416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the influence of adsorbent substances against the antigen activity of inactivated orovaccines.
    Casetta P; Negretti F
    J Chemother; 1992 Jun; 4(3):145-54. PubMed ID: 1517807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunovac-VP4 vaccine used in complex allergen-specific immunotherapy of patients with hay fever].
    Poddubikova AM; Kostinov MP
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (4):44-8. PubMed ID: 20799399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homologous and cross-reacting antibodies in the sera of gnotobiotic rats.
    McLeod JC; Balish E
    Can J Microbiol; 1978 Apr; 24(4):365-71. PubMed ID: 346185
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunological activity of a Proteus vaccine administered to volunteers simultaneously with a pyoimmunogen and adsorbed staphylococcal anatoxin].
    Levina LA; Iurova VA; Kreĭnin LS; Kaverina KG; Dubova VG
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Dec; (12):57-61. PubMed ID: 3128030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.